Lorcaserin

NEW YORK - Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and Nasdaq Stock Market: NYSE NBTY Inc., up $16.27 at $53.74 The Carlyle Group has agreed to buy the vitamin maker for $3.8 billion in cash in the largest private equity deal so far this year.

GAITHERSBURG, MD. - A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug's side effects outweigh its ability to help patients lose weight.

NEW YORK - Shares of obesity drug developers rose Thursday following a report that Arena Pharmaceuticals Inc.'s lorcaserin prompted weight loss without heart-related side effects.